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Robert M Weis 2 and H Shaw Warren 3 
Background: The emergence of bacteria that are resistant to vancomycin (V), 
a glyeopeptide antibiotic, results from the replacement of the carboxy-terminal 
D-Ala-D-Ala of bacterial cell wall precursors by D-Ala-D-lactate. Recently, it has 
been demonstrated that covalent dimeric variants of V are active against 
vancomycin-resistant enterococci (VRE). To study the contribution of divalency 
to the activities of these variants, we modeled the interactions of V and a 
dimeric V with L-Lys-D-Ala-D-lactate, an analog of the cell-wall precursors of 
the vancomycin-resistant bacteria. 
Results: A dimeric derivative of V (V-Rd-V) was found to be much more 
effective than V in inhibiting the growth of VRE. The interactions of V and 
V-Rd-V with a monomeric lactate ligand - -  diaeetyI-L-Lys-o-Ala-D-lactate 
(Ac2KDADLac) - -  and a dimeric derivative of L-Lys-D-Ala-D-lactate 
(Lac-R'd-Lac) in solution have been examined using isothermal titration 
calorimetry and UV spectroscopy titrations; the results reveal that V-Rd-V 
binds Lac-R'd-Lac approximately 40 times more tightly than V binds 
Ac2KDADLac. Binding of V and of V-Rd-V to/V~-Ac-L-Lys-D-Ala-D-lactate 
presented on the surface of mixed self-assembled monolayers (SAMs) of 
alkanethiolates on gold indicates that the apparent off-rate for dissociation 
of V-Rd-V from the surface is much slower than that of V from the 
same surface. 
Conclusions: The results are compatible with the hypothesis that divalency is 
responsible for tight binding, which correlates with small values of minimum 
inhibitory concentrations of V and V-Rd-V. 
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I n t roduct ion  
The emergence of bacteria that are resistant o van- 
comycin (V) - -  an important member of the group of gly- 
copeptide antibiotics that are active against gram-positive 
bacteria - -  is a growing problem in clinical practice [1,2]. 
Vancomycin acts, at least in part, by binding to the 
carboxy-terminal D-Ala-D-AIa (DADA) of the bacterial 
cell wall mucopeptide precursors, and creates a weak 
point in the cell walls; this weak point is believed to 
render the bacterial cells susceptible to lysis [3-7]. One 
mechanism for resistance to V is the replacement of the 
carboxy-terminal DADA by D-Ala-D-lactate (DADLac); 
the change of the amide NH group to an oxygen atom 
greatly decreases the affinity of V to DADLac relative to 
that for DADA [1,2,7,8]. 
Polyvalency has been demonstrated to increase the 
strength of binding in weak-binding systems uccessfully 
[9,10]. We are developing the system of V and PAPA as a 
model with which to study the physical-organic chemistry 
of polyvalency [11-13]. Recent work - -by  Williams and 
coworkers, with noncovalent dimers of V, and by Griffin 
and coworkers, with covalent dimers - -  has suggested 
that these dimers have different activities than mono- 
meric V. Williams and coworkers [14,15] have proposed 
that noncovalent dimerization of V and some of its 
analogs is important for their antibacterial ctivities, and 
recent X-ray crystal structures of V support this model 
[16,17]. Griffin and colleagues [18] also demonstrated 
that dimers were more active against vancomycin-resis- 
tant bacteria by a factor of about 100 than was V itself. 
One possible explanation for this enhanced activity is 
divalent binding to DADLac groups in the cell walls. Here 
we describe a study of the binding of monomeric V and a 
dimeric analog (V-Rd-V) to the DADLac moiety, in solu- 
tion (as both monomer and dimer) and at the surface of a 
self-assembled monolayer (SAM). The results of these 
studies are compatible with the hypothesis that divalency 
can contribute to tight binding and demonstrate that 
tighter binding correlates with better microbiological 
inhibition (therefore lowering the minimum inhibitory 
concentrations) by V-Ra-V. Also the results support he 
hypothesis that divalency contributes to the biological 
activity of these species. 
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The structures of the dimeric vancomycin 
(V-Rd-V) and dimeric lactate ligand 
(Lac-R'd-Lac). 
Results and discussion 
Synthesis of Na-AC-L-LyS-D-Ala-D-lactate and dimeric 
derivative of L-LyS-D-Ala-D-lactate (Lac-R'd-Lac) 
We synthesized V-Rd-V by covalently linking the carboxyl 
terminus of V with a rigid p-xylylenediamine (Figure 1), as 
reported previously [12]. A corresponding dimeric derivative 
of L-Lys-D-AIa-D-Lac (Lac-R'd-Lac) was designed and 
synthesized by forming the amide links to the two (~-amino 
groups of lysine with adipic acid (Figure 1). Ligand 
N~-Ac-L-Lys-D-Ala-D-lactate (AcKDADLac) was synthe- 
sized for surface plasmon resonance studies of V-Rd-V and 
V at the surface of a SAM. 
Microbial assays of activities of V and V-Rd-V 
We tested the antibacterial ctivities of the monomeric 
and dimeric derivatives of V using broth microdilution 
assays (Table 1). V-Rd-V showed activity against van- 
comycin-susceptible gram-positive bacterial strains imilar 
to that of V, but showed substantially higher activity 
against vancomycin-resistant e tcrococci (VRE; Table 1). 
The minimum inhibitory concentration (MIC) value of 
V-Rd-V against vancomycin-resistant E terococcus faecium 
(Van B phenotype) is ~5.6txgJml (1.8gM), and 
-16.7 ktg/ml (5.5 gM) against vancomycin-resistant E. fae- 
calls (Van A phenotype). The reported average MIC value 
Table 1 
Affinity of vancornycin and dimer V-Ra-V for lactate ligands in solution and at the surface, and their in vitro antibacterial activities. 
K d in solution (txM) K d at surface (JAM)* MIC (p,g/ml) 
Ac2KDADLac Lac-R'd-Lac AcKDADLac  AcKDADA [13] Sensitive VRE 
V 660~; 1.7 x 1035 1.8 × 1035 330 1.1 0.3§; 0.6#; 1.91]; 2.1 v >50.0** 
V-Rd-V NB ~ 17.5*; 42.65 <3.3 0.005 0.2§; 9.5#; 1.9¶; 8.3 ~' 5.6~'; 16.7** 
*Determined using SPR spectroscopy over AcKDADLac- or AcKDAoA- 
presenting SAMs; tdetermined using UV difference spectroscopy 
titration in 10 mM phosphate buffer at pH 7.2; ~determined using 
isothermal titration microcalorimetry in 200 mM phosphate buffer at 
pH 7.0 (for V) and 50 mM phosphate buffer at pH 7.0 (for V-Rd-V); 
§against S. pneumoniae; #against alpha hemolytic Streptococcus; 
~lagainst vancomycin-sensitive E. faecalis; ~'against Coagulase-negative 
Staphylococcus;**against E. faecium (Van B phenotype) and E. faecalis 
(Van A phenotype); literature value is 1024 I.tg/ml [18]; ~no binding 
(NB) was observed when titrated M-Rd-V (81 I.tM) with Ac2KDADLaC 
(26.81 mM) in 50 mM phosphate buffer using isothermal titration 
microcalorimetry; **against E. faecium (Van B phenotype); §§against E. 
faecalis (Van A phenotype). 
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Figure 2 
Isothermal titrations of V and V-Rd-V with 
lactate ligands at 25"C. (a) Titration of V 
(2.06 mM) with Ac2KDADLac in 200 mM 
phosphate buffer at pH 7.0 (lower trace), and 
background titration of Ac2KDADLac in the 
absence of V otherwise under the same 
condition (upper trace). (b) Titration of 
V-Rd-V  (64.5 p_M) with the dimeric lactate 
ligand (Lac-R'd-Lac, 7.97 mM) in 50 mM 
phosphate buffer at pH 7.0 (lower trace), and 
background titration of Lac-R'd-Lac (upper 
trace). See the Materials and methods ection 
for experimental details. 
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of V is -1024 ~tg/ml (690 laM) against VRE [18]; V-Rd-V is 
therefore approximately a hundredfold more effective 
than V in inhibiting growth of VRE. 
Interactions of V-Rd-V and V with Lac-R'd-Lac and 
diacetyI-L-Lys-D-Ala-u-lactate in solution 
To examine the contribution of divalency to the antibacter- 
ial activity of V-Rd-V, we compared the affinity of 
Lac-R'o-Lac for V-Rd-V with that of diacetyl-L-Lys-D- 
Ala-D-lactate (AczKDADLac) for V. Isothermal titration 
calorimetry (ITC) [19] and UV difference spectrophotome- 
try [6] were used to characterize the binding of Lac-R'd-Lac 
to V-Rd-V. Representative data from ITC titrations are 
shown in Figure 2. Figure 2a shows a titration of 2.06 mM of 
V with a solution of 53.3 mM of AczKDADLac in 200 mM 
phosphate buffer (pH 7.0) at 25°C, and Figure 2b shows a 
titration of 64 I.tM of V-Rd-V with a solution of 8 mM of 
Lac-R'd-Lac in 50 mM phosphate buffer (pH 7.0) at 25°C. 
The raw titration data were integrated and fitted to the 
single-set-of-sites model to yield values of AH ° and Ka: 
&H°=-3.7kcal/mol and Ka=1745~M for binding of 
AczKDADLac to V, and AH ° = -6.5 kcal/mol and K d = 43 laM 
for binding of Lac-R'd-Lac to V-Rd-V. The binding affinity 
of V-Rd-V to Lac-R'a-Lac is therefore approximately 
40 times tighter than that of V to AczKDADLac. UV differ- 
ence spectrophotometry titrations have been performed in 
20mM phosphate buffer: K d of AczKDADLac for 
V = 660 p_M, and K d of Lac-R'a-Lac for V-Rd-V = 17.5 ~tM. 
It was consistent with ITC results that the binding of 
V-Rd-V to Lac-R'd-Lac is also approximately 40 times 
stronger than that of V to AczKDADLac. The reason why the 
values of K d determined using ITC were about threefold 
larger than those determined using UV titrations was not 
clear; part of this difference might be due to a difference in 
the ionic strength of the two buffer solutions. 
In comparing the thermodynamic data describing the 
binding of V to diacetyl-L-Lys-D-Ala-D-Ala with those of 
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Table 2 
Thermodynamic parameters of binding of vancomycin 
derivitives to depsipeptide/peptide ligands at 298K. 
AG ° AH* -Tz~S* 
Receptor L igand (kcal/mol) (kcal/mol) (kcal/mol) 
V Ac2KDADLac -3.8 -3.7 -0.1 
V-Rd-V Lac-R'd-Lac -6.0 -6.5 0.5 
V* Ac2KDADA -7.9 -12.8 4.9 
Values of AH* were determined by duplicated ITC titrations at pH 7.0 in 
phosphate buffer at 298K; values for the free energy AG ° were 
calculated from Kd, measured in the same solution; values of -TAS ° 
were calculated from AG ° = AHO-TAS °. *Measured in 20 mM phosphate 
buffer at 298K; the results agree well with the literature values [27]. 
V to AczKDADLac (Table 2), it is interesting to note that 
the replacement of the amide in diacetyl-L-Lys-D-Ala-D- 
Ala by an ester bond in AczKDADLac results in a much 
smaller binding enthalpy but also a smaller entropic loss. 
This type of enthalpy/entropy compensation has been dis- 
cussed in other contexts by Searle and Williams [20]. The 
loss of one hydrogen bond seems to loosen greatly the 
binding interface between V and AczKDADLac. 
The reported imerization constant of V is about 700 M -1 
[21]; at the concentrations of V we used in the experi- 
ments, V could partly exist as the noncovalent dimer. The 
ITC data, however, did not show any of the cooperativity 
observed by Williams et al. [22] in their study of the 
binding of V with diacetyl-L-Lys-D-Ala-D-Ala. A possible 
reason could be that the binding of V to DADLac is so 
weak that the ligand-induced cooperative binding by 
DADLac is too small to be observed. 
We also examined the interaction between V and Lac- 
R'd-Lac by ITC. We treated the two sites of Lac-R'd-Lac 
identically in analyzing the data to obtain affinities; the 
average dissociation constant (K d = 1835 ~M; Table 1) was 
similar to that between V and AczKDADLac. Moreover, 
Figure 3 
under conditions similar to those used in the titration of 
V-Rd-V (64/.tM) with Lac-R'd-Lac, ITC titration showed 
no detectable binding of V-Rd-V (81gM) with 
AczKDADLac. These results established that binding is 
enhanced only between the dimeric V and the dimeric 
ligand. Comparison of the thermodynamic parameters for 
the monovalent binding of V to AczKDADLac (Table 2) with 
those of the binding of V-Rd-V to Lac-R'd-Lac larified the 
origin of the enhanced affinity of the divalent binding--  
AAH ° = -2.8 kcal/mol, and TAAS ° = -0.6 kcal/mol. The 
observation that enthalpy increased without a large compen- 
sating loss in entropy is compatible with the hypothesis that 
divalency is the basis for the enhanced affinity of 
Lac-R'd-Lac for V-Rd-V. 
Surface plasmon resonance spectroscopy study of V and 
V-Rd-V at the surface of a SAM presenting N'-Ac-L-Lys - 
D-Ala-D-lactate 
The interactions that determine the antibacterial ctivities 
of V and its derivatives occur at the surface of the cell 
membrane of the bacterium (i.e. the interface between 
the cell membrane and the peptidoglycan layer of the cell 
wall). To model this interaction, we have examined the 
interactions of V-Rd-V and V with DADLac at the surface 
of a SAM. The combination of surface plasmon resonance 
(SPR) spectroscopy and SAMs of alkanethiolates on gold 
provides an easily manipulated and highly sensitive analy- 
tical system with which to study molecular ecognition at 
surfaces [13,23]. 
We treated SAMs of 16-mercaptohexadecanoic ac d on 
gold with trifluoroacetic anhydride and triethylamine in 
anhydrous N, N-dimethylformamide to generate $AMs of 
the interchain carboxylic anhydride (Figure 3) [24]. The 
AcKDADLac was immobilized at the surface of SAMs by 
subsequent treatment of the anhydride substrate with a 
10 mM solution of AcKDADLac (pH = 10). The resulting 
mixed SAMs presented AcKDADLac and COOH groups at 
the surface; the mole fraction of AcKDADLac groups in the 
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Preparation of mixed SAMs on gold 
presenting/%~-Ac-L-Lys-o-Ala-o-lactate 
(AcKDAoLac), 
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Figure 4 
The binding of V to mixed SAM presenting 
AcKDADLac groups. The inset is a 
Scatchard plot of these data; RUeq is the 
equilibrium response (1"= 10,000 RU). RU, 
resonance units. 
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mixed SAMs was ~(AcKDADLac) --0.50 and that of COOH was 
Z(COOH)-0"50) [13]. We then examined the interaction of 
vancomycin (at concentrations ranging from 2.15 mM to 
47 I-tM) with these SAMs. The increase in the amplitude of 
the SPR signal on adding V suggested that V was binding 
to AcKDADLac at the SAM; the rate of dissociation of V 
from the surface (koff) was, however, too fast (> 0.5 s -1) to be 
estimated accurately (Figure 4). We therefore stimated 
the affinity of V with AcKDADLac at the SAMs using 
Scatchard analysis. The values Ofko#and ko, are sufficiently 
high that V in solution reaches equilibrium with V bound 
to AcKDADLac at the surface. Scatchard analysis of the 
equilibrium amount of V bound to AcKDADLac at the 
surface as a function of the concentration fV in the buffer 
solutions yielded a value of/~d,~ -0.33 raM. Comparison of 
the binding at the surface with that in solution indicates 
that the value at the surface is twofold or sixfold smaller 
than that in solution (depending on the value chosen for 
comparison; Table 1). The sensorgrams ofbinding indicate 
that less than 10% of V remains at the surface after the 
binding. The nonspecific interaction between V and the 
surface presenting AcKDADLac is, at least in part, responsi- 
ble for the tighter binding at the surface measured in our 
system than that in solution. 
The affinity of V for AcKDADLac on SAMs 
(K d -0.33 mM) is 300-fold less than that for N~-Ac-L- 
Lys-D-Ala-D-AIa on SAMs (K d-l .1 ~tM) [13]. The MIC 
values of V for VRE are approximately a thousandfold 
larger than those for vancomycin-susceptible strains. 
Those observations--a weak binding and fast dissocia- 
tion of V observed in this model system--suggest that 
the weak interaction between V and AcKDADLac on 
SAMs correlates (and perhaps models) the weak antibacte- 
rial activity of V against vancomycin-resistant bacteria 
using DADLac as the cell wall precursors. 
We then examined the interaction of V-Rd-V (at con- 
centrations from 4.0 ~tM to 10 riM) with AcKDADLac on 
the SAMs under the same experimental conditions 
(Figure 5). The interaction was substantially different 
from that between V and AcKDADLac: the dissociation 
of V-Rd-V was much slower than that of V. Analysis of 
the dissociation regions gave a value of the apparent off- 
rate of about 5 × 10 -3 s-l; this value was at least 100 
times slower than that of V from the same surface 
(> 0.5 s-l). Due to the complexity introduced into the 
analysis of the data by mass transport in the binding of 
V-Rd-V at the surface, we were not able to estimate the 
on-rate. By assuming that the on-rate of V-Rd-V is 
similar to that of V, we could estimate the upper limit of 
the binding affinity of V -RcV at the surface as 
</~a%/100 -3.3 pM. 
The maximum response in the binding of V-Rd-V 
observed by SPR is higher than that in the binding of V by 
about 600 resonance units (Figure 5). We suspect that this 
larger value of resonance units might result from at least 
one other binding mode--monovalent b inding--and 
nonspecific adsorption of V-Rd-V at high concentrations 
of V-Rd-V. In principle, V-Rd-V can also bind monova- 
lently with AcKDADLac and therefore give a larger SPR 
response than bivalent binding. The higher the concentra- 
tion of V-Rd-V, the more important he monovalent 
binding mode, and the more serious the nonspecific 
adsorption of V-Rd-V by the SAM surface. 
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Figure 5 
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The binding of V-Rd-V to a mixed SAM presenting AcKDADLac 
groups. 
The SPR studies indicate that V-Rd-V binds the lactate 
ligand AcKDADLac, when present at a high surface 
density ()~ = 0.50), more than I00 times more tightly than 
does V. This result correlates well with the observation i  
the microbiological study that the MIC values of V-Rd-V 
against VRE are approximately 100 times smaller than 
that of V, and is consistent with the hypothesis that diva- 
lency contributes to the antibacterial ctivity. 
Significance 
This study proposes a model system with which to 
examine one possible contribution to the enhanced activ- 
ity of a dimeric derivative of vancomycin (V) against 
vancomyein-resistant bacteria. Understanding the origin 
of this enhanced activity might suggest leads to the 
design of other antibiotics effective against vancomycin- 
resistant bacteria. 
The data from our study of this model system have 
demonstrated a correlation between the antibacterial 
activity of V and a dimeric derivative of V (V-Rd-V) 
against vancomycin-resistant bacteria and their binding 
affinities with their lactate ligands in solution and at the 
surface. V-Rd-V binds more tightly to a dimeric lactate 
ligand Lac-R'd-Lac in solution than does V, binds more 
tightly to a monomeric lactate ligand AcKDADLac at the 
surface than does V, and is more effective in inhibiting the 
growth of vancomycin-resistant enterococci than is V. 
This correlation between divalency, tight binding and 
antibacterial ctivity cannot, however, be applied to the D- 
AIa-D-AIa ligands and vancomycin-susceptible bacteria: 
although V-Rd-V  binds more tightly with a dimeric D- 
AIa-D-AIa ligand in solution [12] and AcKDADA at the 
surface than does V [13], it is not more effective than V 
against vancomycin-susceptible acteria. The reasons 
why this correlation exists for vancomycin-resistant bac- 
teria but not for vancomycin-susceptible bacteria re not 
currently clear to us, and suggest that there be important 
aspects of the antibiotic activity of vancomycin that are 
not adequately described by current mechanisms of this 
activity [3-7]. 
Materials and methods 
Vancomycin hydrochloride was purchased from Sigma and used 
without further purification. V-Rd-V was available from previous 
studies [12,13]. Amino acids including Ac2KDADLac were purchased 
from Sigma except D-Ala-O-tBu from BACHEM Bioscience, and the 
peptide-coupling reagent 2-(1H-benzotriazol-l-yl)-l,l,3,3-tetramethy- 
luronium hexafluorophosphate (HBTU) was purchased from Applied 
Biosystem. Part of AcKDADLac used in our study was synthesized 
according to reported procedures [25], and part was purchased from 
BACHEM Bioscience. 
Synthesis of Lac-R'd-Lac 
To 300 mg (0.5?6 mmol) of N a-t-boc-N~-Ac-L-Lys-D-Ala-D-Lac-O - 
Benzyl ester (synthesized as literature reported procedures [25]) and 
39 mg of adipic acid (0.26? mmol) in 10 ml of acetonitrile solution was 
added 231 mg of HBTU (0.609 mmol) and 157 mg of diisopropylthey- 
lamine (1.217 mmol). The reaction was stirred at room temperature 
overnight; a white, cloudy precipitate formed. The precipitate was col- 
lected after filtration and washed with saturated NaCI and ethyl acetate. 
The hexadepsi-peptide ster (230 mg) was obtained as white solid 
(0.242 mmol, 84O/o). The crude ester was dissolved in absolute ethanol 
and hydrogenated over 5% palladium on activated carbon overnight. The 
reaction mixture was then filtered through a bed of Celite, and the filtrate 
was evaporated and purified using HPLC to afford the final depsipep- 
tide. ~H-NMR (400 MHz, DMSO-de) 8.34 (d, 2H), 7.83 (d, 2H), 7.78 (t, 
2H), 4.92 (q, 2H), 4.27 (m, 4H), 2.96 (q, 4H), 2.10 (m, 4H), 1.78 (s, 6H), 
1.63-1.53 (m, 2H), 1.52-1.41 (m, 5H), 1.39 (d, 6H), 1.37-1.31 (m, 4H), 
1.27 (d, 6H), 1.25-1.15 (m, 4H); FAB-MS, for 032H54NaO12Na 
(M + Na+), calc'd m/z ?95.3?52, found m/z 795.3735. 
Isothermal titration calorimetry 
Titrations were carried out using a MicroCal MGS titration calorimeter 
with Observer software for instrument control, data acquisition and analy- 
sis. Instrumentation, software and data analysis have been described 
elsewhere [19]. Titration buffers were 200 or 50 mM phosphate buffer at 
pH 7.0 as indicated. Titrations typically consisted of 3 BI or 5 BI injections 
in a schedule of 20-30 injections spaced at intervals of 4-5 min and a 
syringe speed of 500 rpm. The concentrations of V-Rd-V were deter- 
mined using UV-Vis absorption spectrometry assuming that the value of 
E28o of V-Rd-V was double of that of V (for V, ~o~ E1 cmat 280 nm= 45 [6]). 
Antibiotic broth microdilution assays 
MIC values of antibiotics were determined for each organism exactly as 
described by the National Committee for Clinical Laboratory Standards 
[26]. The bacteria studied were clinical strains obtained from Massa- 
chusetts General Hospital Microbiology Laboratory. Bacteria, adjusted 
to appropriate bacterial densities in Mueller-Hinton broth supple- 
mented with divalent cations (and in some cases lysed horse blood), 
were incubated with dilutions of the vancomycin compounds for 
16-20 h at 37"C. MIC value was determined as the lowest concentra- 
tion of antibiotic allowing no visible growth. 
Preparation of mixed SAMs 
The gold substrates were prepared by electron beam evaporation 
of 1.5 nm of titanium and 38 nm of gold onto glass cover slips as 
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previously described [24]. The gold-coated slips were cut into approxi- 
mately 1 cm x 2 cm pieces and washed with absolute ethanol before 
adsorption of alkanethiol. SAMs were prepared by overnight exposure 
of the freshly prepared substrates to a 2 mM ethanolic solution of 16- 
mercaptohexadecanoic a id at room temperature in a 20 ml scintillation 
vial. The resulted SAMs were immersed in a 10 ml solution of 0.1 M tri- 
fluoroacetic anhydride and 0.2 M triethylamine in anhydrous N, N- 
dimethylformamide for 20 min at room temperature, removed and 
rinsed thoroughly with dichloromethane, and dried in a stream of nitro- 
gen. The substrates of the interchain anhydride were treated with a 
10 mM solution of AcKDAoLac (pH = 10) and afforded mixed SAMs 
with a ligand density of approximately 0.50. 
Surface p lasmon resonance measurements 
SPR measurements were made with a BIACore instrument (Pharma- 
cia Biosensor), and were conducted with a constant 5 t.d/min flow of 
solution over the surfaces. The binding of vancomycin or the dimeric 
vancomycin was carried out by sequential injection of 10 I~1 of PBS 
solution. The surface was washed with PBS after each injection. The 
dissociation of vancomycin or the dimeric vancomycin resulted in a 
shift in the resonance angle that was reported in resonance units 
(RU; 10,000 RU = 1.0°). The data were analyzed using the program 
provided by BIACore. 
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